EP2094578B1 - Behälter - Google Patents
Behälter Download PDFInfo
- Publication number
- EP2094578B1 EP2094578B1 EP07824165A EP07824165A EP2094578B1 EP 2094578 B1 EP2094578 B1 EP 2094578B1 EP 07824165 A EP07824165 A EP 07824165A EP 07824165 A EP07824165 A EP 07824165A EP 2094578 B1 EP2094578 B1 EP 2094578B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- cup
- vessel
- container according
- container
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Not-in-force
Links
- 239000003814 drug Substances 0.000 claims abstract description 42
- 239000012530 fluid Substances 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000001681 protective effect Effects 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 4
- 238000009517 secondary packaging Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/18—Arrangements of closures with protective outer cap-like covers or of two or more co-operating closures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/24—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
- B65D51/28—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes with auxiliary containers for additional articles or materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2251/00—Details relating to container closures
- B65D2251/0003—Two or more closures
- B65D2251/0006—Upper closure
- B65D2251/0015—Upper closure of the 41-type
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2251/00—Details relating to container closures
- B65D2251/0003—Two or more closures
- B65D2251/0068—Lower closure
- B65D2251/0078—Lower closure of the 41-type
Definitions
- This invention relates to a container useful in the storing and taking of medicaments.
- the medication may be in the form of a tablet or a capsule, or a powdered form which needs to be dissolved in water.
- a user needs to carry a drink with them or to purchase a drink to help swallow the medicament.
- US 6,419,081 describes a combined pill and water container.
- One version of the container comprises a cylindrical housing which is divided into separate water and pill-storing compartments. The compartments are accessed via removable end caps at opposite ends of the cylindrical housing.
- Another version of the container has a cylindrical housing for retaining water and a smaller tubular container which fits within the cylindrical housing.
- One disadvantage of this container is that a user must drink directly from the liquid-retaining compartment of the container, which is undesirable, or must find a separate cup (not forming part of the container) and dispense part of the liquid into the cup.
- a further disadvantage of this container is that a user cannot readily determine how much of the liquid they have consumed. This results in the container only being of practical use for a single dose of a medicament.
- WO-A-9 936 319 discloses an integrated bottle and cap assembly comprising pills encapsulated in a cap containing a peel-off seal. The present invention seeks to provide an improved container useful for the storage and consumption of medicaments.
- a container for use in the storage of and consumption of a medicament comprising:
- An advantage of the container is that a user has both a medicament and a fluid, for example a liquid such as water, to help consume the medicament in a single convenient package.
- the container could be, for example, kept in a car, handbag or rucksack when travelling and avoids the need to separately carry a drink or to purchase a drink, when medication is required.
- Providing a cup as a part of the container also allows a user to dispense part of the liquid from the vessel, while retaining some of the liquid for a second dose of medication at a later time.
- the cup can also be used to dissolve a soluble medicament.
- the cup may further, advantageously, be provided with a visible indication which indicates a liquid fill level or quantity.
- the container may be used in a hospital and/or pharmacy environment for administering medication.
- the container will advantageously facilitate the provision of a correct medication, optionally taken with an optimal amount of fluid as contained in the vessel and/or measurable in the cup.
- the cup may be dimensioned to overlie an outer wall of the vessel over at least part of the length of the vessel.
- the cup may be dimensioned to overlie the vessel such that the cup has a length of substantially one half of the overall length of the container.
- the vessel may comprise an outer wall which is stepped such that the vessel has a first portion, nearest the first end, which has a narrower cross-section than a second portion.
- the cup may be dimensioned such that when the cup is fitted to the vessel, the cup overlies the first portion of the vessel and the outer profile of the cup is continuous with the second portion of the vessel in the region where the cup joins the second portion. This improves the physical handling of the container and physical appearance of the container.
- the closure may be resealable. This allows a user to consume only part of the liquid and to seal the remaining liquid within the vessel, and also allows the vessel to be refilled and reused.
- the medicament-retaining compartment may comprise a space formed between the closure and an end face of the cup when the cap and cup are fitted to the vessel.
- a medicament may be packaged and either: loosely held within the cup; attached to the cup; or attached to the closure.
- the package has a maximum dimension which is substantially equal to (just smaller than) interior dimension of the compartment where the package is to be housed.
- the package can have a lid which is just smaller than the compartment.
- the cup may have has at least one physical feature for limiting movement of the protective package within the compartment. This helps to prevent the package from excessive movement, thus preventing damage to the medicament and avoiding a need to secure the package within the compartment.
- the cup may have a fluid capacity (or "volume") which is substantially 30-70%, for example 40-60% or 45-45%, such as 50%, of a fluid capacity of the vessel.
- the vessel has a fluid capacity of substantially 60ml to less than 100 ml.
- the container has a generally cylindrical shape.
- the container may have rounded end caps to allow the container to be handled more easily.
- the container has a diameter which allows it to be comfortably grasped by a single hand.
- Alternative shapes for a container according to the invention are possible, including for example a generally oval or egg shape, cylindrical, or polygonal (for example, an elongated box-shape, which may be useful for storing the container in bulk).
- the external surface of the vessel and/or cup may include physical formations which allow them to be easily grasped, and for the cup to be removed without slipping.
- the vessel and/or cup may comprise a substantially flat base to allow the container to be stored in a vertical position.
- the vessel and/or cup may comprise a flattened portion to allow the container to be stored in a horizontal position.
- the container may comprise an attachment means, for example a hook, to allow the container to be attached to a corresponding fitting for storage.
- an attachment means for example a hook
- All or an externally visible part of the vessel and/or cup may be formed from a transparent, or substantially transparent, material, so that the contents of the container may be visible, for example for inspection by a user, or a security official.
- an opaque vessel and/or cup are also envisaged, for example where it is necessary to avoid light contamination of the fluid and/or medication in the container.
- a part or all of the container, preferably externally visible parts of the container may be coloured. Different coloured containers could, for example, be used to denote different medications and/or fluid retained within the container.
- the container may be a single use, disposable item. Alternatively, the container may be re-usable.
- FIG. 1 shows the components of an embodiment of the container in a disassembled form.
- the container comprises a vessel 10 as shown in Figure 2 for storing a quantity of liquid.
- the liquid will typically be water, although any other liquid can be stored within the vessel 10.
- the vessel 10 has an opening 15 at one end, which is defined by a neck portion 17.
- a cap 20 is provided for fitting to the neck 17 of the vessel, and provides a liquid-tight seal of the opening 15.
- a screw thread 16 is formed around the neck 17 of the vessel and a complementary screw thread is formed on an interior surface of the cap 20.
- the vessel 10 has a flat base 18 which allows the vessel to stand upright on a surface, such as when filling the vessel with liquid.
- the cap 20 should be easy to grip, allowing a user to remove the cap 20 and replace it easily. Formations, such as ridges, can be provided on the cap 20 to allow ease of handling.
- Part 30 serves as a combined cup and lid.
- Part 30 is dimensioned to fit over the upper portion 12 of the vessel.
- the outer profile of the vessel is narrower in portion 12 than in portion 11, and a radial step 14 joins the two portions 11, 12.
- Features 13 on the outer surface of portion 12 of the vessel, and features 31 on the interior surface 30 of the cup 30, cooperate to retain the cup on the vessel.
- the cup 30 secures to the vessel with a simple twist thread fitting although according to the invention any other suitable fitting, such as a snap fitting, can be used.
- the fitting may allow the elderly, or those suffering from arthritis, to easily separate the cup and vessel but be secure enough to hold the cup and vessel, and any enclosed medicaments, securely together.
- An alternative fitting may comprise a child-proof fitting.
- the container resembles a capsule when assembled.
- the size of the container is specific in relation to the amount or dosage of the medicine, thus allowing the container to fit comfortably into a pocket or handbag.
- the embodiment shown in the Figures has a generally cylindrical shape, which makes the container particularly suited for front end counter displays and vending machines.
- the cup 30 has a length which is approximately 50% of the total length of the assembled container. As shown in Figure 5 , the cup 30 has a volume of approximately 50% of the volume of the vessel 10.
- a printed marking, or a physical formation can be provided on the vessel 10 and/or the cup 30 to indicate a fill level. Additional markings or formations can be provided on the vessel 10 and/or the cup 30 to indicate particular volumes (e.g. 10 ml, 20 ml, 30 ml), which is advantageous if a medicament needs to be taken with a particular quantity of liquid or if a soluble medicament needs to be taken with a particular quantity of liquid.
- the volume of the vessel may be less than 100ml, as this allows a passenger to carry the container as hand luggage during current air travel regulations regarding travelling with liquids.
- a particularly advantageous volume for the vessel 10 has been found to be approximately 60ml, as illustrated in the example shown in Figure 5 , with the cup 30 having a capacity of 50% (i.e. 30ml in the example shown) of the capacity of the vessel 10. This has been found to be the most comfortable and visually appealing to potential retail buyers. It is advantageous that at least the vessel 10 is formed from a transparent, or substantially transparent, material, so that the contents are visible for inspection by a user, or a security official.
- a separate cap 20 is provided for sealing the opening 15 of the vessel 10.
- a closure can be provided as part of the cup 30 for sealing the inlet 15.
- the closure can be a screw-fit cap which positively locates within the cup 30, such that when the cup 30 is turned, the cap turns with the cup 30.
- the compartment 40 can be accessed by removing the cap from within the cup 30.
- the closure for the vessel can be formed integrally with the cup 30 and the compartment 40 can be accessed by removing an additional sealed cover within the closure.
- the container of the invention can be provided in a reusable form, or as a single use, disposable item.
- the cap 20 is resealable to the neck 17 of the vessel, and the fitting between cup 30 and vessel 10 allows the cup to be refitted to the vessel 10.
- the container may be sold pre-filled with liquid and/or medicament, or as an empty container.
- a user refills the vessel 10 with liquid of their choice, fits the cap 20 to the vessel 10 to seal the inlet, and then places one or more doses of a chosen medicament on top of the cap 20, or within the cup 30 and secures the cup 30 to the vessel 10.
- the cap of the container can comprise a removable seal, such as a foil top which is heat bonded to the lip of inlet 15.
- the foil seal can have a tab for easy removal.
- the container is sold pre-filled with liquid (e.g. water) and with a medicament which is either stored as a separately packaged item, freely positioned within the compartment 35 of the cup 30, or within a compartment within the lid of the cup 30, such as a foil topped compartment.
- the container can be supplied with a plastic over wrapping or security seal to indicate that the contents have not been tampered with.
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Packages (AREA)
- Glass Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Closures For Containers (AREA)
Claims (16)
- Behälter zur Verwendung bei der Aufbewahrung und Einnahme eines Medikaments, umfassend:ein Gefäß (10) zur Aufbewahrung einer Fluidmenge, wobei das Gefäß an einem ersten Ende eine Öffnung hat,einen Verschluss (20) zum dichten Verschließen der Öffnung in dem Gefäß,einen Becher (30), der so dimensioniert ist, dass er um das erste Ende des Gefäßes (10) passt, so dass der Becher mit dem ersten Ende des Gefäßes in das Innere des Bechers hineinragend aufbewahrt werden kann und so dass, wenn der Becher an dem Gefäß angebracht ist, zwischen dem Becher und dem Verschluss eine Medikamentaufnahmekammer, die einen Raum (35) umfasst, gebildet wird, undein Medikament in der Medikamentaufnahmekammer,wobei das Gefäß ein Fluidfassungsvermögen von 60 ml bis weniger als 100 ml hat,wobei der Becher (30) ein Fluidfassungsvermögen hat, das im Wesentlichen 30 - 70 % des Fluidfassungsvermögens des Gefäßes ist,wobei das Medikament in einer Schutzpackung aufbewahrt wird, wobei die Schutzpackung lose in dem die Medikamentaufnahmekammer bildenden Raum (35) aufgenommen ist, wobei der Raum (35), in dem die Schutzpackung aufgenommen ist, in direktem Kontakt mit dem Inneren des Bechers ist, undwobei die Anordnung dergestalt ist, dass der Becher vor Verkauf und Öffnen als sekundäre Verpackung dient.
- Behälter nach Anspruch 1, bei dem der Becher (30) so dimensioniert ist, dass er auf wenigstens einem Teil der Länge des Gefäßes eine Außenwand (12) des Gefäßes (10) überlagert.
- Behälter nach Anspruch 2, bei dem der Becher (30) so dimensioniert ist, dass er das Gefäß (10) auf wenigstens einem Viertel der Gesamtlänge des Gefäßes überlagert.
- Behälter nach Anspruch 2 oder 3, bei dem der Becher (30) so dimensioniert ist, dass er das Gefäß (10) so überlagert, dass der Becher eine Länge von im Wesentlichen der Hälfte der gesamten Länge des Behälters hat.
- Behälter nach einem der Ansprüche 2 bis 4, bei dem das Gefäß (10) eine Außenwand (11, 12) aufweist, die abgestuft ist, so dass das Gefäß einen ersten, dem ersten Ende am nächsten liegenden Abschnitt (12) hat, der einen schmaleren Querschnitt als ein zweiter Abschnitt (11) hat.
- Behälter nach Anspruch 5, bei dem der Becher so dimensioniert ist, dass, wenn der Becher (30) an dem Gefäß angebracht ist, der Becher den ersten Abschnitt (12) des Gefäßes überlagert und ein äußeres Profil des Bechers in der Region, in der der Becher an den zweiten Abschnitt anschließt, mit dem zweiten Abschnitt des Gefäßes kontinuierlich ist.
- Behälter nach einem der vorhergehenden Ansprüche, bei dem der Verschluss eine wiederverschließbare Kappe (20) umfasst, wobei die Medikamentaufnahmekammer zwischen der Kappe und einer Endfläche des Bechers (30) gebildet wird, wenn die Kappe und der Becher an dem Gefäß angebracht sind.
- Behälter nach einem der vorhergehenden Ansprüche, ferner umfassend einen Haltemechanismus zum Festhalten des Bechers in einer an dem Gefäß angebrachten Position.
- Behälter nach einem der vorhergehenden Ansprüche, bei dem der Becher wenigstens ein physisches Merkmal (36) zur Begrenzung der Bewegung des Medikaments innerhalb der Kammer hat.
- Behälter nach einem der vorhergehenden Ansprüche, bei dem die Schutzverpackung eine Blisterpackung ist.
- Behälter nach einem der vorhergehenden Ansprüche, bei dem das Fluid eine Flüssigkeit ist, z.B. Wasser wie sterilisiertes oder reines oder Quellwasser.
- Behälter nach einem der vorhergehenden Ansprüche, bei dem das Gefäß (20) und/oder der Becher (30) eine im Wesentlichen flache Basis aufweist bzw. aufweisen, damit der Behälter in einer senkrechten Position gelagert werden kann.
- Behälter nach einem der vorhergehenden Ansprüche, bei dem der Becher ein Fluidfassungsvermögen hat, das im Wesentlichen 40 - 60 % des Fluidfassungsvermögens des Gefäßes ist.
- Behälter nach einem der vorhergehenden Ansprüche, bei dem der Becher ein Fluidfassungsvermögen hat, das im Wesentlichen 50 % des Fluidfassungsvermögens des Gefäßes ist.
- Behälter nach einem der vorhergehenden Ansprüche, bei dem der Behälter ein Fluidfassungsvermögen von im Wesentlichen 60 ml hat.
- Behälter nach einem der vorhergehenden Ansprüche, bei dem der Verschluss eine abnehmbare Abdichtung umfasst.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0620877A GB0620877D0 (en) | 2006-10-20 | 2006-10-20 | Medication and drink unit |
| GB0714271A GB0714271D0 (en) | 2007-07-21 | 2007-07-21 | Container |
| PCT/GB2007/003914 WO2008047087A1 (en) | 2006-10-20 | 2007-10-12 | Container |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2094578A1 EP2094578A1 (de) | 2009-09-02 |
| EP2094578B1 true EP2094578B1 (de) | 2010-12-08 |
Family
ID=38805795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP07824165A Not-in-force EP2094578B1 (de) | 2006-10-20 | 2007-10-12 | Behälter |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2094578B1 (de) |
| AT (1) | ATE490930T1 (de) |
| DE (1) | DE602007011108D1 (de) |
| WO (1) | WO2008047087A1 (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105640767A (zh) * | 2015-12-26 | 2016-06-08 | 青岛朝阳华泰管理咨询服务有限公司 | 一种便携式药剂瓶 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210154095A1 (en) * | 2019-11-22 | 2021-05-27 | Flp, Llc | Container for pet products |
| US11377274B2 (en) * | 2020-11-02 | 2022-07-05 | Altria Client Services Llc | Multi-chambered container |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2296761A (en) * | 1939-12-29 | 1942-09-22 | William G Beckers | Container for medicament substance or the like |
| US3415360A (en) * | 1966-12-19 | 1968-12-10 | Dentaire Ivoclar Ets | Receptacle for dental preparations |
| FR2290366A1 (fr) * | 1974-11-08 | 1976-06-04 | Contrapac | Flacon pour le conditionnement de deux produits a melanger a l'interieur ulterieurement |
| IL79754A0 (en) * | 1986-08-18 | 1986-11-30 | Res & Dev Co Ltd | Container for creams |
| FR2616322A1 (fr) * | 1987-06-11 | 1988-12-16 | Cassin Jamet Nelly | Dispositif aseptique de mise en solution de composants reactifs |
| US6513650B2 (en) * | 1997-10-14 | 2003-02-04 | Biogaia Ab | Two-compartment container |
| AU2323699A (en) * | 1998-01-20 | 1999-08-02 | Garrison Leigh | Integrated bottle and bottle cap assembly |
| AU6066799A (en) * | 1999-11-26 | 2001-05-31 | Lily Hsu | Container device for separately enclosing two different substances |
| DE20103937U1 (de) * | 2000-08-31 | 2001-06-28 | Sausse, Hans-Georg, 20249 Hamburg | Verschluß in Form eines Deckels oder einer Kappe für Behälter |
| ITMO20050058A1 (it) * | 2005-03-15 | 2006-09-16 | Lameplast Spa | Confezione per prodotti a preparazione estemporanea, particolarmente medicinali, farmaceutici, cosmetici o simili. |
-
2007
- 2007-10-12 DE DE602007011108T patent/DE602007011108D1/de active Active
- 2007-10-12 AT AT07824165T patent/ATE490930T1/de not_active IP Right Cessation
- 2007-10-12 EP EP07824165A patent/EP2094578B1/de not_active Not-in-force
- 2007-10-12 WO PCT/GB2007/003914 patent/WO2008047087A1/en not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105640767A (zh) * | 2015-12-26 | 2016-06-08 | 青岛朝阳华泰管理咨询服务有限公司 | 一种便携式药剂瓶 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008047087A1 (en) | 2008-04-24 |
| ATE490930T1 (de) | 2010-12-15 |
| EP2094578A1 (de) | 2009-09-02 |
| DE602007011108D1 (de) | 2011-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1521709B1 (de) | Verfahren und vorrichtung zum dosieren von flüssigen nahrungsergänzungsmitteln | |
| US20090050514A1 (en) | Dual compartment medicine container | |
| US6860390B2 (en) | Medicine organizer device | |
| US20060124658A1 (en) | Pill dispenser with patient compliant indicating means | |
| US20140360966A1 (en) | Dual compartment container for holding solid and liquid | |
| US20080000786A1 (en) | Combination Ingestible-Product and Beverage Packaging | |
| US20120228184A1 (en) | Medicament dispenser and associated methods | |
| US20110253737A1 (en) | Cartridge based dispenser system | |
| US20110147252A1 (en) | Packages and inserts useful for dispensing medicines | |
| CA3219779A1 (en) | Cap assembly for reusable medicine container, and uses thereof | |
| US20190380910A1 (en) | Device for packaging two products to be mixed and for dispensing the mixture of these products | |
| US20110132795A1 (en) | Package with enclosure for dispensing doses of a medicament | |
| US20110155757A1 (en) | Packages and inserts thereof with guide wall for dispensing medicinal units | |
| EP2094578A1 (de) | Behälter | |
| US8074817B1 (en) | Method and apparatus for metering liquid nutritional supplements | |
| EP3856655B1 (de) | Behälterverschlusssystem | |
| US20190112113A1 (en) | Drug delivery and patient reminder system | |
| ES1318989U (es) | Envase para dosificador de medicamentos solidos | |
| US20090025883A1 (en) | Essential nomenclature safety labeler (ENSL) | |
| GB2318783A (en) | Container for drinks and medication | |
| RU100368U1 (ru) | Флакон с сувениром | |
| KR20110002531U (ko) | 보조수용부가 구비된 뚜껑 | |
| CN118811281A (zh) | 具有易开启和易饮用液体特征的双配方包装袋 | |
| ES1264279U (es) | Botella con dispensador de producto encapsulado | |
| MXPA01006628A (es) | Tapon con compartimiento adicional. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20090514 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| 17Q | First examination report despatched |
Effective date: 20090922 |
|
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REF | Corresponds to: |
Ref document number: 602007011108 Country of ref document: DE Date of ref document: 20110120 Kind code of ref document: P |
|
| RAP4 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: MCCLUSKEY, KENNETH Owner name: FREWIN, JONATHAN LEE |
|
| RIN2 | Information on inventor provided after grant (corrected) |
Inventor name: FREWIN, JONATHAN LEE Inventor name: MCCLUSKEY, KENNETH |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20101208 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 |
|
| LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20101208 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110308 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110408 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110408 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110309 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110319 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 |
|
| 26N | No opposition filed |
Effective date: 20110909 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602007011108 Country of ref document: DE Effective date: 20110909 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20111031 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20111031 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20111031 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20111012 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20121031 Year of fee payment: 6 Ref country code: DE Payment date: 20121023 Year of fee payment: 6 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20111012 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101208 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602007011108 Country of ref document: DE Representative=s name: MEISSNER, BOLTE & PARTNER GBR, DE Ref country code: DE Ref legal event code: R082 Ref document number: 602007011108 Country of ref document: DE Representative=s name: MEISSNER BOLTE PATENTANWAELTE RECHTSANWAELTE P, DE |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602007011108 Country of ref document: DE Representative=s name: MEISSNER, BOLTE & PARTNER GBR, DE |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602007011108 Country of ref document: DE Effective date: 20140501 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20140630 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131031 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140501 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20211129 Year of fee payment: 15 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20221012 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221012 |